Summary
This prediction ended on 09.02.24 with a price of €9.56. The SELL prediction by Marianka finished with a performance of 29.19%. Marianka has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Altimmune | 3.403% | 3.403% |
| iShares Core DAX® | 0.238% | -2.265% |
| iShares Nasdaq 100 | -0.304% | 5.808% |
| iShares Nikkei 225® | 2.271% | 1.577% |
| iShares S&P 500 | -0.296% | 4.447% |
According to Marianka what are the pros and cons of Altimmune for the foreseeable future?
Pros
Good culture
Innovative
Sustainability is important
Cons
overvalued
negative Cash Flow expected
Very little Investments for future growth
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Below average Management
Few uniques
High risks for its business
Below average Marketposition
Significant cyclical dependencies
Business model of the past or high risk
Revenue decline > 20% expected
Decining EBIT margin than peer group
Very low/no dividend yield expected
Bad rating
Growths much slower than the competition
high free float
Probably not worthwhile Investment
EBIT decline > 20% expected
Dependend from few customers or products
Little known brand